1Bressler NM, Bressler SB, Fine SL. Neovascular (exudative) age-related macular degeneration. In Retina, Vol 3 Medical Retina. Ryan SJ.Eds. Philadelphia. Mosby comp. 2006;1075-1089.
2Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) Study Group, Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: twoyear results of 2 randomized clinical trials. TAP report no. 2. Arch Ophthalmol 2001;119:198-207.
3Sternberg P, Lewis H. Photodynamic therapy for age-related macular degeneration: acandid apprasial. Am J Ophthalmol 2004;137:483-485.
4Ishibashi T, M iki K, Sorgente N, et al. Effects of intravitreal administration of steroids on experimental subretinal neovascularization in subhuman primate. Arch Ophthalmol 1985;103:708-711.
5Gillies MC, Simpson JM, Lou W, et al. A randomized clinical trial of single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Arch Ophthalmol 2003;121:667-673.
6Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Am J Ophthalmol 2003;110:1517-1525.
7Verteporfin in Photodynamic Therapy (VIP) Study Group. Photodynamic therapy of subfoveal choroidal eovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization. VIP report no. 2. Am J Ophthalmol 2001;131:541-560.
8Verteporfin in Photodynamic Therapy (VIP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia: with verteporfin: Oneyear results of a randomized clinical trial. VIP report no.1. Ophthalmology 2001;108:841-852.
9Krebs I, Binder S, Stolba U, et al. Choroidal neovascularization in pathologic myopia: three-year results after photodynamic therapy. Am J Ophtalmol 2005;140:416-425.
10Verteporfin in Ocular Histoplasmosis (VOH) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization with vertoporfin in ocular histoplasmosis syndrome one-year results of an uncontrolled, prospective case series. Ophthalmology 2002;109:1499-1505.
11Karaçorlu M, Karaçorlu S, Bürümcek E, Özdemir H. Yaşa baglı makula dejenerasyonunda fotodinamik tedavi uygulamasının klasik koroid neovaskularizasyonlu olgular ile klasik+gizli koroid neovaskularizasyonlu olgulardaki 6 aylık takip sonuçları. Türk Oftalmoloji Gazetesi 2002; 32:832-837.
12Karaçorlu S, Özdemir H, Karaçorlu M. Patolojik miyopiye baglı subfoveal koroid neovaskülarizasyonu olgularında fotodinamik tedavi. Türk Oftalmoloji Gazetesi 2002;32:769-774.
13Karaçorlu M, Karaçorlu S, Özdemir H. Klasik koroid neovaskülarizasyonlu ve gizli koroid neovaskülerizasyonlu yaşa baglı makula dejenerasyonu olgularındaki fotodinamik tedavi uygulamasının 12 aylık takip sonuçları. Retina-Vitreus 2003;11:13-18.
14Yetik H, Müftüoglu G, Akar S, ve ark. Oküler fotodinamik tedavide 24 aylık sonuçlarımız. Retina-Vitreus 2005;13:173-178.
15Akar S. Koroid neovaskülarizasyonlarının tedavisinde fotodinamik tedavi. Retina-Vitreus 2005;13:9-12.
16Sönmez K, Atmaca LS. Yaşa baglı makula dejeneresansı-nın tedavisinde yenilikler. Türkiye Klinikleri Cerrahi Tıp Bilimleri 2006;2:38-47.
17Menteş J. Fotodinamik tedavi. Türkiye Klinikleri Cerrahi Tıp Bilimleri 2006;2:30-37.
18Koçak N, Karahan E, Öner FH, ve ark. Anjioid streaks'e baglı gelişen koroid neovaskülarizasyonunda argon lazer fotokoagülasyon ve fotodinamik tedavi sonuçları. Retina- Vitreus 2006;14:263-268.
19Altan T, Kapran Z, Yalçın O, ve ark. Yaşa baglı maküla dejenerasyonunda subfoveal koroidal neovaskülarizasyonun verteporfin ile fotodinamik tedavisinin orta ve uzun dönem sonuçları. Retina-Vitreus 2006;14:169-174.
20Atsam N, Özmert E, Batıoglu F. Yaşa baglı maküla dejeneresanslı retinal anjiomatöz proliferasyon ve polipoidal koroidal vaskülopati olgularında fotodinamik/kombine tedavi sonuçları. Retina-Vitreus 2007;15:81-86.
21Öner A, Özkırış A, Karaküçük S, ve ark. Fotodinamik tedavide 18 aylık sonuçlarımız. Erciyes Tıp Dergisi 2007;29:35-39.
22Bardak Y, Çekiç O, Tıg Ş, Kendir F. Subfoveal koroid neovaskularizasyonlu yaşa baglı maküla dejenerasyonunda oküler fotodinamik tedavi sonuçlarımız. Türk Oftalmoloji Gazetesi 2007;37:447-452.
23Ishibashi T, Hata Y, Yoshikawa H, et al. Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 1997;235:159-167.
24Cui JZ, Kimura H, Spee C, et al. Natural history of choroidal neovascularization induced by vascular endothelial growth factor in the primate. Graefes Arch Clin Exp Ophthalmol 2000;238:326-333.
25Challa JK, Gillies MC, Penfold PL, et al. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow-up. Aust N Z J Ophtalmol 1998;26:277- 281.
26Gillies MC, Simson JM, Billson FA, et al. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch Ophtalmol 2004;122:336-340.
27Augustin AJ, Schmidt-Erfurth U. Vertoporfin therapy and triamcinolone acetonide: convergent modes of action for treatment of neovascular age related macular degeneration.Eur J Ophtalmology 2006;16:824-834.
28Michels S, Schmidt-Erfurth U. Sequence of early vascular events after photodynamic therapy. Invest Ophthalmol Vis Sci 2003;44:2147-2154.
29Schmidt-Erfurth U, Schlotzer-Schrehard U, Cursiefen C,et al. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 2003;44:4473-4480.
30Ruiz-Moreno JM, Montero JA, Barile S, Zarbin MA. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome. Retina 2006;26:602-612.
31Spaide RF, Sorenson J, Maranan L. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2005;112:301-304.
32Augustin AJ, Schmidt-Erfurth U. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 2006;141:638-645.
33Ergun E, Maar N, Ansari-Shahrezaei S, et al. Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration. Am J Ophthalmol 2006;142:10-16.
34Kumar A, Sinha S, Kumar V. Visual acuity and contrast sensitivity outcomes in Indian eyes undergoing photodynamic therapy with intravitreal injection of triamcinolone acetonide in age-related macular degeneration. Indian Journal of Ophtalmolgy 2007;55:207-211.
35Rechtman E, Danis RP, Pratt LM, Harris A. Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol 2004;88:344-347.